VOTING AGREEMENTVoting Agreement • January 30th, 2017 • Biomark Capital Fund Iv Lp • Biological products, (no disgnostic substances) • Delaware
VOTING AGREEMENT, dated as of January 21, 2017 (this “Agreement”), by and among Biotest Pharmaceuticals Corporation, a Delaware corporation (“Seller”), ADMA Biologics, Inc., a Delaware corporation (the “Company”), and each of the Persons listed on Schedule 1 hereto (each, a “Stockholder”, and to the extent more than one Person is listed, collectively, the “Stockholders”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in the Purchase Agreement (hereinafter defined).
Exhibit A Agreement of Joint FilingJoint Filing Agreement • January 30th, 2017 • Biomark Capital Fund Iv Lp • Biological products, (no disgnostic substances)
This Agreement of Joint Filing may be executed in counterparts, each of which shall be deemed to be an original instrument, but all of the counterparts together shall constitute one agreement.
